msgpackr 1.4.7 → 1.5.3

package/tests/benchmark.cjs

@@ -1,199 +0,0 @@
-var msgpackr = tryRequire("../dist/node.cjs");
-var msgpack_node = tryRequire("msgpack");
-var msgpack_msgpack = tryRequire("@msgpack/msgpack");
-var msgpack_lite = tryRequire("msgpack-lite");
-var msgpack_js = tryRequire("msgpack-js");
-var msgpack_js_v5 = tryRequire("msgpack-js-v5");
-var msgpack5 = tryRequire("msgpack5");
-var msgpack_unpack = tryRequire("msgpack-unpack");
-var msgpack_codec = tryRequire("msgpack.codec");
-var notepack = tryRequire("notepack");
-var what_the_pack = tryRequire("what-the-pack");
-var avro = tryRequire('avsc')
-var cbor = tryRequire('cbor')
-
-msgpack5 = msgpack5 && msgpack5();
-msgpack_codec = msgpack_codec && msgpack_codec.msgpack;
-what_the_pack = what_the_pack && what_the_pack.initialize(2**20);
-
-var pkg = require("../package.json");
-var data = require("./example4.json");
-var packed = msgpack_lite && msgpack_lite.encode(data);
-var expected = JSON.stringify(data);
-
-var argv = Array.prototype.slice.call(process.argv, 2);
-
-if (argv[0] === "-v") {
-  console.warn(pkg.name + " " + pkg.version);
-  process.exit(0);
-}
-
-var limit = 5;
-if (argv[0] - 0) limit = argv.shift() - 0;
-limit *= 1000;
-
-var COL1 = 58;
-var COL2 = 7;
-var COL3 = 5;
-var COL4 = 6;
-
-console.log(rpad("operation", COL1), "|", "  op  ", "|", "  ms ", "|", " op/s ");
-console.log(rpad("", COL1, "-"), "|", lpad(":", COL2, "-"), "|", lpad(":", COL3, "-"), "|", lpad(":", COL4, "-"));
-
-var buf, obj;
-
-if (msgpackr) {
-  let packr = new msgpackr.Packr({ useRecords: false })
-  buf = bench('require("msgpackr").pack(obj);', msgpackr.pack, data);
-    //buf = bench('require("msgpackr").pack(obj);', data => {let result = packr.pack(data); packr.resetMemory(); return result;}, data);
-
-  obj = bench('require("msgpackr").unpack(buf);', msgpackr.unpack, buf);
-  test(obj);
-
-  packr = new msgpackr.Packr({ structures: [] })
-  buf = bench('msgpackr w/ shared structures: packr.pack(obj);', packr.pack.bind(packr), data);
-  //buf = bench('msgpackr w/ shared structures: packr.pack(obj);', data => {let result = packr.pack(data); packr.resetMemory(); return result;}, data);
-
-  obj = bench('msgpackr w/ shared structures: packr.unpack(buf);', packr.unpack.bind(packr), buf);
-  test(obj);
-}
-
-if (JSON) {
-  buf = bench('buf = Buffer(JSON.stringify(obj));', JSON_stringify, data);
-  obj = bench('obj = JSON.parse(buf);', JSON.parse, buf);
-  test(obj);
-}
-
-if (msgpack_lite) {
-  buf = bench('buf = require("msgpack-lite").encode(obj);', msgpack_lite.encode, data);
-  obj = bench('obj = require("msgpack-lite").decode(buf);', msgpack_lite.decode, packed);
-  test(obj);
-}
-
-if (msgpack_msgpack) {
-  buf = bench('buf = require("@msgpack/msgpack").encode(obj);', msgpack_msgpack.encode, data);
-  obj = bench('obj = require("@msgpack/msgpack").decode(buf);', msgpack_msgpack.decode, buf);
-  test(obj);
-}
-
-if (msgpack_node) {
-  buf = bench('buf = require("msgpack").pack(obj);', msgpack_node.pack, data);
-  obj = bench('obj = require("msgpack").unpack(buf);', msgpack_node.unpack, buf);
-  test(obj);
-}
-
-if (msgpack_codec) {
-  buf = bench('buf = Buffer(require("msgpack.codec").msgpack.pack(obj));', msgpack_codec_pack, data);
-  obj = bench('obj = require("msgpack.codec").msgpack.unpack(buf);', msgpack_codec.unpack, buf);
-  test(obj);
-}
-
-if (msgpack_js_v5) {
-  buf = bench('buf = require("msgpack-js-v5").encode(obj);', msgpack_js_v5.encode, data);
-  obj = bench('obj = require("msgpack-js-v5").decode(buf);', msgpack_js_v5.decode, buf);
-  test(obj);
-}
-
-if (msgpack_js) {
-  buf = bench('buf = require("msgpack-js").encode(obj);', msgpack_js.encode, data);
-  obj = bench('obj = require("msgpack-js").decode(buf);', msgpack_js.decode, buf);
-  test(obj);
-}
-
-if (msgpack5) {
-  buf = bench('buf = require("msgpack5")().encode(obj);', msgpack5.encode, data);
-  obj = bench('obj = require("msgpack5")().decode(buf);', msgpack5.decode, buf);
-  test(obj);
-}
-
-if (notepack) {
-  buf = bench('buf = require("notepack").encode(obj);', notepack.encode, data);
-  obj = bench('obj = require("notepack").decode(buf);', notepack.decode, buf);
-  test(obj);
-}
-if (what_the_pack) {
-  buf = bench('require("what-the-pack")... encoder.encode(obj);', what_the_pack.encode, data);
-  obj = bench('require("what-the-pack")... encoder.decode(buf);', what_the_pack.decode, buf);
-  test(obj);
-}
-
-if (msgpack_unpack) {
-  obj = bench('obj = require("msgpack-unpack").decode(buf);', msgpack_unpack, packed);
-  test(obj);
-}
-
-if (avro) {
-  const type = avro.Type.forValue(data);
-  buf = bench('require("avsc")...make schema/type...type.toBuffer(obj);', type.toBuffer.bind(type), data);
-  obj = bench('require("avsc")...make schema/type...type.fromBuffer(obj);', type.fromBuffer.bind(type), buf);
-}
-if (cbor) {
-  buf = bench('buf = require("cbor").encode(obj);', cbor.encode, data);
-  obj = bench('obj = require("cbor").decode(buf);', cbor.decode, buf);
-  test(obj);
-}
-
-function JSON_stringify(src) {
-  return Buffer(JSON.stringify(src));
-}
-
-function msgpack_codec_pack(data) {
-  return Buffer(msgpack_codec.pack(data));
-}
-
-function bench(name, func, src) {
-  if (argv.length) {
-    var match = argv.filter(function(grep) {
-      return (name.indexOf(grep) > -1);
-    });
-    if (!match.length) return SKIP;
-  }
-  var ret, duration;
-  var start = new Date() - 0;
-  var count = 0;
-  while (1) {
-    var end = new Date() - 0;
-    duration = end - start;
-    if (duration >= limit) break;
-    while ((++count) % 100) ret = func(src);
-  }
-  name = rpad(name, COL1);
-  var score = Math.floor(count / duration * 1000);
-  count = lpad(count, COL2);
-  duration = lpad(duration, COL3);
-  score = lpad(score, COL4);
-  console.log(name, "|", count, "|", duration, "|", score);
-  return ret;
-}
-
-function rpad(str, len, chr) {
-  if (!chr) chr = " ";
-  while (str.length < len) str += chr;
-  return str;
-}
-
-function lpad(str, len, chr) {
-  if (!chr) chr = " ";
-  str += "";
-  while (str.length < len) str = chr + str;
-  return str;
-}
-
-function test(actual) {
-  if (actual === SKIP) return;
-  actual = JSON.stringify(actual);
-  if (actual === expected) return;
-  console.warn("expected: " + expected);
-  console.warn("actual:   " + actual);
-}
-
-function SKIP() {
-}
-
-function tryRequire(name) {
-  try {
-    return require(name);
-  } catch (e) {
-    // ignore
-  }
-}

package/tests/example.json

@@ -1,52 +0,0 @@
-{
-  "int0": 0,
-  "int1": 1,
-  "int1-": -1,
-  "int8": 255,
-  "int8-": -255,
-  "int16": 256,
-  "int16-": -256,
-  "int32": 65536,
-  "int32-": -65536,
-  "nil": null,
-  "true": true,
-  "false": false,
-  "float": 0.5,
-  "float-": -0.5,
-  "string0": "",
-  "string1": "A",
-  "string4": "foobarbaz",
-  "string8": "Omnes viae Romam ducunt.",
-  "string16": "L’homme n’est qu’un roseau, le plus faible de la nature ; mais c’est un roseau pensant. Il ne faut pas que l’univers entier s’arme pour l’écraser : une vapeur, une goutte d’eau, suffit pour le tuer. Mais, quand l’univers l’écraserait, l’homme serait encore plus noble que ce qui le tue, puisqu’il sait qu’il meurt, et l’avantage que l’univers a sur lui, l’univers n’en sait rien. Toute notre dignité consiste donc en la pensée. C’est de là qu’il faut nous relever et non de l’espace et de la durée, que nous ne saurions remplir. Travaillons donc à bien penser : voilà le principe de la morale.",
-  "array0": [],
-  "array1": [
-    "foo"
-  ],
-  "array8": [
-    1,
-    2,
-    4,
-    8,
-    16,
-    32,
-    64,
-    128,
-    256,
-    512,
-    1024,
-    2048,
-    4096,
-    8192,
-    16384,
-    32768,
-    65536,
-    131072,
-    262144,
-    524288,
-    1048576
-  ],
-  "map0": {},
-  "map1": {
-    "foo": "bar"
-  }
-}

package/tests/example2.json

@@ -1,26 +0,0 @@
-{"widget": {
-    "debug": "on",
-    "window": {
-        "title": "Sample Konfabulator Widget",
-        "name": "main_window",
-        "width": 500,
-        "height": 500
-    },
-    "image": { 
-        "src": "Images/Sun.png",
-        "name": "sun1",
-        "hOffset": 250,
-        "vOffset": 250,
-        "alignment": "center"
-    },
-    "text": {
-        "data": "Click Here",
-        "size": 36,
-        "style": "bold",
-        "name": "text1",
-        "hOffset": 250,
-        "vOffset": 100,
-        "alignment": "center",
-        "onMouseUp": "sun1.opacity = (sun1.opacity / 100) * 90;"
-    }
-}}   

package/tests/example3.json

@@ -1,22 +0,0 @@
-{
-    "glossary": {
-        "title": "example glossary",
-		"GlossDiv": {
-            "title": "S",
-			"GlossList": {
-                "GlossEntry": {
-                    "ID": "SGML",
-					"SortAs": "SGML",
-					"GlossTerm": "Standard Generalized Markup Language",
-					"Acronym": "SGML",
-					"Abbrev": "ISO 8879:1986",
-					"GlossDef": {
-                        "para": "A meta-markup language, used to create markup languages such as DocBook.",
-						"GlossSeeAlso": ["GML", "XML"]
-                    },
-					"GlossSee": "markup"
-                }
-            }
-        }
-    }
-}

package/tests/example4.json

@@ -1 +0,0 @@
-{"metadata":{"Designs":["Randomized Controlled Trial"],"Types":[],"BriefSummary":"To determine the efficacy, long-term safety, and tolerability of alirocumab 300 mg every 4\n weeks (Q4W), in comparison with placebo, as well as its potential as a starting regimen. The\n dose regimen of 75 mg every 2 weeks (Q2W), as used in other studies, was added as a\n calibrator.","Abstract":"To determine the efficacy, long-term safety, and tolerability of alirocumab 300 mg every 4\n weeks (Q4W), in comparison with placebo, as well as its potential as a starting regimen. The\n dose regimen of 75 mg every 2 weeks (Q2W), as used in other studies, was added as a\n calibrator.","Acronym":null,"ArticleId":"Qy3gwKWSoaWRmbmFEQA","Authors":null,"CochraneID":null,"Confidential":false,"CorporateAuthor":null,"Country":"Bulgaria, Canada, Hungary, Israel, Norway, Slovakia, United Kingdom, United States","CustomData":null,"DatabaseType":"ClinicalTrials.gov","DOI":null,"EmbaseAccessionNumber":null,"Emtree":null,"ErrataText":null,"FullTextURL":null,"Institution":null,"ISSN":null,"Issue":null,"JournalTitle":null,"MedlineID":null,"MeSH":"Hypercholesterolemia|Antibodies, Monoclonal","Pages":null,"ParentChildStatus":null,"ParentID":null,"PublicationDate":"March 21, 2017","PublicationYear":2017,"PubType":null,"ReferenceStudy":null,"SecondarySourceID":null,"Source":"Regeneron Pharmaceuticals","SourceReferenceId":"NCT01926782","TaStudyDesign":"Randomized","Title":"A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of an Every Four Weeks Treatment Regimen of Alirocumab in Patients With Primary Hypercholesterolemia","TrialOutcome":null,"Volume":null,"Id":179246831,"Created":"2020-04-10T14:48:20.4384957Z","VersionNo":2,"ExtractData":null,"Digitized":true,"IsRapidExtract":false,"IsUploaded":false},"design":"Randomized Controlled Trial","conditions":[{"label":"Cholesterol Total Increased","id":"SUE_c"}],"phase":3,"name":"NCT01926782","trialIds":["NCT01926782"],"acronyms":[],"outcomeCount":156,"id":179246831,"groups":[{"Id":"4r","RefId":"B5|O2~Alirocumab 75 mg Q2W/Up 150 mg Q2W Without Concomitant Statin","OriginalName":"Alirocumab 75 mg Q2W/Up 150 mg Q2W Without Concomitant Statin","N":37,"age":59.3,"ageSD":11.3,"male":37.83783783783784,"Interventions":[{"termIds":[["SUBYEL","SUB_Oc"],["SUNUVb"]]}],"analyzeAs":"Alirocumab","analyzableScore":1.0717734625362931,"matchingScore":0},{"Id":"zB","RefId":"B6|O3~Alirocumab 300 mg Q4W/Up 150 mg Q2W Without Concomitant Statin","OriginalName":"Alirocumab 300 mg Q4W/Up 150 mg Q2W Without Concomitant Statin","N":146,"age":59.2,"ageSD":10.8,"male":45.205479452054796,"Interventions":[{"termIds":[["SUBYEL","SUB_Oc"]]}],"analyzeAs":"Statins","analyzableScore":1.0717734625362931,"matchingScore":0},{"Id":"3!","RefId":"B4|O1~Placebo Q2W Without Concomitant Statin","OriginalName":"Placebo Q2W Without Concomitant Statin","N":73,"age":59.4,"ageSD":10.2,"male":54.794520547945204,"Interventions":[{"termIds":[["SUGeLS"],["SUBYEL","SUB_Oc"]]}],"analyzeAs":"Control","analyzableScore":1.2020833333333334,"matchingScore":0},{"Id":"tv","RefId":"E3","OriginalName":"Alirocumab 300 mg Q4W/Up 150 mg Q2W","Interventions":[{"termIds":[["SUCO54","SUNUVb"]]}]},{"Id":"jt","RefId":"B3|O3~Alirocumab 300 mg Q4W/Up 150 mg Q2W With Concomitant Statin","OriginalName":"Alirocumab 300 mg Q4W/Up 150 mg Q2W With Concomitant Statin","N":312,"age":61.6,"ageSD":10,"male":60.8974358974359,"Interventions":[{"termIds":[["SUBYEL","SUB_Oc"]]}]},{"Id":"5!","RefId":"E2","OriginalName":"Alirocumab 75 mg Q2W/Up 150 mg Q2W","Interventions":[{"termIds":[["SUNUVb"]]}]},{"Id":"4E","RefId":"B2|O2~Alirocumab 75 mg Q2W/Up 150 mg Q2W With Concomitant Statin","OriginalName":"Alirocumab 75 mg Q2W/Up 150 mg Q2W With Concomitant Statin","N":78,"age":60.7,"ageSD":9.1,"male":65.38461538461539,"Interventions":[{"termIds":[["SUBYEL","SUB_Oc"],["SUNUVb"]]}]},{"Id":"i4","Interventions":[{"Id":"Ya","Name":178613599,"Treatments":[{"Id":"((","Phase":"k)"}],"Type":"Drug","termIds":[["SUGeLS"],["SUNUVb"]],"terms":[["Placebo"],["Alirocumab"]]},{"Id":"o)","Name":2159990,"Treatments":[{"Id":"1$","Phase":"k)"}],"Type":"Drug","termIds":[["SUBYEL"]],"terms":[["Statins"]]}],"RefId":"E1|Placebo Q2W","OriginalName":"Placebo Q2W"},{"Id":"Ls","RefId":"B1|O1~Placebo Q2W With Concomitant Statin","OriginalName":"Placebo Q2W With Concomitant Statin","N":157,"age":61.6,"ageSD":9.7,"male":64.3312101910828,"Interventions":[{"termIds":[["SUGeLS"],["SUBYEL","SUB_Oc"]]}]}],"hasDocData":true,"hasRapidExtract":false,"N":803,"queryScore":1.4868329805051381,"matchingScore":7.960635921410255,"score":22.084654254966498,"outcomes":[{"id":"179246387","type":"Change","unit":"%","termIds":[["SUF0R","SUBskP"]],"quantifiers":[],"name":"Calculated LDL-C in Not Receiving Concomitant Statin Therapy - On-Treatment Analysis","cells":[{"number":-0.4,"unit":"%","group":"3!","varType":"se","N":70,"se":2,"sd":16.73},{"number":-54.6,"unit":"%","group":"4r","varType":"se","N":37,"se":2.8,"sd":17.03},{"number":-59.4,"unit":"%","group":"zB","varType":"se","N":141,"se":1.4,"sd":16.62}],"time":{"Id":67122072,"Low":{"Value":"Baseline"},"High":{"Number":24,"Unit":"wk"},"Type":"Total","days":168,"description":"24wk"},"score":2.08,"matchingTerm":"SUF0R","suggestedPositive":false,"sourceUnit":"%"},{"id":"179246389","type":"Change","unit":"%","termIds":[["SUF0R","SUBskP"]],"quantifiers":[],"name":"Calculated LDL-C in Receiving Concomitant Statin Therapy - On-Treatment Analysis","cells":[{"number":-0.3,"unit":"%","group":"Ls","varType":"se","N":151,"se":2.1,"sd":25.81},{"number":-55.1,"unit":"%","group":"4E","varType":"se","N":75,"se":3,"sd":25.98},{"number":-62.3,"unit":"%","group":"jt","varType":"se","N":302,"se":1.5,"sd":26.07}],"time":{"Id":67122072,"Low":{"Value":"Baseline"},"High":{"Number":24,"Unit":"wk"},"Type":"Total","days":168,"description":"24wk"},"score":2.08,"matchingTerm":"SUF0R","suggestedPositive":false,"sourceUnit":"%"},{"id":"179246393","type":"Change","unit":"%","termIds":[["SUF0R","SUBskP"]],"quantifiers":[],"name":"Calculated LDL-C in Not Receiving Concomitant Statin Therapy - On-Treatment Analysis","cells":[{"number":-0.5,"unit":"%","group":"3!","varType":"se","N":70,"se":2,"sd":16.73},{"number":-53.9,"unit":"%","group":"4r","varType":"se","N":37,"se":2.7,"sd":16.42},{"number":-60,"unit":"%","group":"zB","varType":"se","N":141,"se":1.4,"sd":16.62}],"time":{"Id":67122069,"Low":{"Value":"Baseline"},"High":{"Number":12,"Unit":"wk"},"Type":"Total","days":84,"description":"12wk"},"score":2.08,"matchingTerm":"SUF0R","suggestedPositive":false,"sourceUnit":"%"},{"id":"179246394","type":"Change","unit":"%","termIds":[["SUF0R","SUBskP"]],"quantifiers":[],"name":"Calculated LDL-C in Receiving Concomitant Statin Therapy - On-Treatment Analysis","cells":[{"number":1.4,"unit":"%","group":"Ls","varType":"se","N":151,"se":1.9,"sd":23.35},{"number":-47.3,"unit":"%","group":"4E","varType":"se","N":75,"se":2.8,"sd":24.25},{"number":-58,"unit":"%","group":"jt","varType":"se","N":302,"se":1.4,"sd":24.33}],"time":{"Id":67122069,"Low":{"Value":"Baseline"},"High":{"Number":12,"Unit":"wk"},"Type":"Total","days":84,"description":"12wk"},"score":2.08,"matchingTerm":"SUF0R","suggestedPositive":false,"sourceUnit":"%"}],"characteristics":[{"id":"179246354","type":"Binary","isCharacteristic":true,"termIds":[["SUE_c","SUCbN","SUyJj"]],"quantifiers":[],"name":"Patients not having adequate control of their hypercholesterolemia based on their individual level of CVD risk","cells":[],"number":100}],"outcomesScore":18.97947630112307}

package/tests/example5.json

@@ -1,12 +0,0 @@
-{
-  "name": "test",
-  "greeting": "Hello, World!",
-  "flag": true,
-  "littleNum": 3,
-  "biggerNum": 32254435,
-  "decimal":1.332232,
-  "bigDecimal": 3.5522E35,
-  "negative": -54,
-  "aNull": null,
-  "more": "another string"
-}

package/tests/floats.json

@@ -1 +0,0 @@
-[0.53232,542.5325,3252200000,6643.2,0.000000432,1.992e20,5.1,9.3242e-20,525.235,8899.32,522.42,2342.43,12211.1,8888.3,0.000432]

package/tests/index.html

@@ -1,28 +0,0 @@
-<html>
-<head>
-	<style>
-		body {
-			font-family: sans-serif;
-		}
-		h1 {
-			font-size: 18px;
-		}
-		h2 {
-			font-size: 16px;
-		}
-	</style>
-</head>
-<body>
-	<script src="../node_modules/mocha/mocha.js"></script>
-	<script src="../node_modules/chai/chai.js"></script>
-	<script>
-		mocha.setup('tdd')
-	</script>
-	<script src="../dist/index.js"></script>
-	<script src="../dist/test.js"></script>
-	<div id="mocha"></div>
-	<script>
-		mocha.run()
-	</script>
-</body>
-</html>

package/tests/sample-large.json

@@ -1,231 +0,0 @@
-[
-   {
-      "_id":"56490c18d9275a0003000000",
-      "author":null,
-      "created_at":"2015-11-15T22:50:00.170Z",
-      "description":"A weekly discussion by Ruby developers about programming, life, and careers.",
-      "image":"https://s3.amazonaws.com/devchat.tv/ruby-rogues-thumb.jpg",
-      "keywords":[
-         "Business",
-         "Careers",
-         "Technology",
-         "Software How-To"
-      ],
-      "language":"en",
-      "permalink":"http://rubyrogues.com/",
-      "published":true,
-      "title":"The Ruby Rogues",
-      "updated_at":"2015-11-15T22:50:06.565Z",
-      "url":"http://feeds.feedwrench.com/RubyRogues.rss"
-   },
-   {
-      "_id":"56490d6ad9275a00030000eb",
-      "author":null,
-      "created_at":"2015-11-15T22:55:38.074Z",
-      "description":"Um podcast feito para programadores e empreendedores.",
-      "image":"http://www.grokpodcast.com/images/logo_itunes_grande.png",
-      "keywords":[
-         "Technology",
-         "Podcasting",
-         "Business",
-         "Careers"
-      ],
-      "language":"pt-BR",
-      "permalink":"http://www.grokpodcast.com/",
-      "published":true,
-      "title":"Grok Podcast",
-      "updated_at":"2015-11-15T22:55:47.498Z",
-      "url":"http://www.grokpodcast.com/atom.xml"
-   },
-   {
-      "_id":"564a1c30b1191d0003000000",
-      "author":null,
-      "created_at":"2015-11-16T18:10:56.610Z",
-      "description":"The Web Platform Podcast is a developer discussion that dives deep into ‘all things’ web. We discuss everything from developing for mobile to building HDTV software. From wearables \u0026 robotics to user experience \u0026 mentoring, we bring to our listeners everything related to building products \u0026 services for The Web Platform of today, tomorrow, and beyond.",
-      "image":"http://static.libsyn.com/p/assets/f/7/2/0/f7208dae16d0543e/twp-logo-flat-blue-square.png",
-      "keywords":[
-         "Technology",
-         "Software How-To",
-         "Tech News"
-      ],
-      "language":"en",
-      "permalink":"http://thewebplatform.libsyn.com/webpage",
-      "published":true,
-      "title":"The Web Platform Podcast",
-      "updated_at":"2015-11-16T18:11:02.022Z",
-      "url":"http://thewebplatform.libsyn.com//rss"
-   },
-   {
-      "_id":"564a1de3b1191d0003000047",
-      "author":null,
-      "created_at":"2015-11-16T18:18:11.854Z",
-      "description":"Developer Tea is a podcast for web and software developers hosted by a developer that you can listen to in less than 10 minutes. The show will cover a wide variety of topics related to the career of being a developer. We hope you'll take the topics from this podcast and continue the conversation, either online or in person with your peers. The show is hosted by Jonathan Cutrell, Director of Technology at Whiteboard and the author of Hacking the Impossible, a developer's guide to working with visionaries. :: Twitter: @developertea @jcutrell :: Email: developertea@gmail.com",
-      "image":"http://simplecast-media.s3.amazonaws.com/podcast/image/363/1440374119-artwork.jpg",
-      "keywords":[
-         "Technology",
-         "Business",
-         "Careers",
-         "Society \u0026 Culture"
-      ],
-      "language":"en-us",
-      "permalink":"http://www.developertea.com/",
-      "published":true,
-      "title":"Developer Tea",
-      "updated_at":"2015-11-16T23:00:23.224Z",
-      "url":"http://feeds.feedburner.com/developertea"
-   },
-   {
-      "_id":"564a3163e51cc0000300004c",
-      "author":null,
-      "created_at":"2015-11-16T19:41:23.436Z",
-      "description":"Conference talks from the Remote Conferences series put on by Devchat.tv",
-      "image":"https://s3.amazonaws.com/devchat.tv/RemoteConfs.jpg",
-      "keywords":[
-
-      ],
-      "language":"en",
-      "permalink":"http://remoteconfs.com/",
-      "published":true,
-      "title":"Remote Conferences - Audio",
-      "updated_at":"2015-11-16T19:41:24.367Z",
-      "url":"http://feeds.feedwrench.com/remoteconfs-audio.rss"
-   },
-   {
-      "_id":"564a315de51cc00003000000",
-      "author":null,
-      "created_at":"2015-11-16T19:41:17.492Z",
-      "description":"Weekly discussion by freelancers and professionals about running a business, finding clients, marketing, and lifestyle related to being a freelancer.",
-      "image":"https://s3.amazonaws.com/devchat.tv/freelancers_show_thumb.jpg",
-      "keywords":[
-         "Business",
-         "Careers",
-         "Management \u0026amp; Marketing",
-         "Education",
-         "Training"
-      ],
-      "language":"en",
-      "permalink":"http://www.freelancersshow.com/",
-      "published":true,
-      "title":"The Freelancers' Show",
-      "updated_at":"2015-11-16T19:41:27.459Z",
-      "url":"http://feeds.feedwrench.com/TheFreelancersShow.rss"
-   },
-   {
-      "_id":"564a3169e51cc000030000cd",
-      "author":null,
-      "created_at":"2015-11-16T19:41:29.686Z",
-      "description":"React Native Radio Podcast",
-      "image":"https://s3.amazonaws.com/devchat.tv/react-native-radio-album-art.jpg",
-      "keywords":[
-
-      ],
-      "language":"en",
-      "permalink":"http://devchat.tv/react-native-radio",
-      "published":true,
-      "title":"React Native Radio",
-      "updated_at":"2015-11-16T19:41:29.999Z",
-      "url":"http://feeds.feedwrench.com/react-native-radio.rss"
-   },
-   {
-      "_id":"564a316fe51cc000030000d4",
-      "author":null,
-      "created_at":"2015-11-16T19:41:35.937Z",
-      "description":"The iOS Development Podcast",
-      "image":"https://s3.amazonaws.com/devchat.tv/iPhreaks-thumb.jpg",
-      "keywords":[
-         "Technology",
-         "Tech News",
-         "Software How-To"
-      ],
-      "language":"en",
-      "permalink":"http://iphreaksshow.com/",
-      "published":true,
-      "title":"The iPhreaks Show",
-      "updated_at":"2015-11-16T19:41:43.700Z",
-      "url":"http://feeds.feedwrench.com/iPhreaks.rss"
-   },
-   {
-      "_id":"564a3184e51cc00003000156",
-      "author":null,
-      "created_at":"2015-11-16T19:41:56.874Z",
-      "description":"Weekly podcast discussion about Javascript on the front and back ends. Also discuss programming practices, coding environments, and the communities related to the technology.",
-      "image":"https://s3.amazonaws.com/devchat.tv/javascript_jabber_thumb.jpg",
-      "keywords":[
-         "Education",
-         "Training",
-         "Technology",
-         "Software How-To"
-      ],
-      "language":"en",
-      "permalink":"http://javascriptjabber.com/",
-      "published":true,
-      "title":"JavaScript Jabber",
-      "updated_at":"2015-11-16T19:42:24.692Z",
-      "url":"http://feeds.feedwrench.com/JavaScriptJabber.rss"
-   },
-   {
-      "_id":"564a31dee51cc00003000210",
-      "author":null,
-      "created_at":"2015-11-16T19:43:26.390Z",
-      "description":"Each week we explore an aspect of web security.",
-      "image":"http://devchat.cachefly.net/websecwarriors/logo_3000x3000.jpeg",
-      "keywords":[
-
-      ],
-      "language":"en",
-      "permalink":"http://websecuritywarriors.com/",
-      "published":true,
-      "title":"Web Security Warriors",
-      "updated_at":"2015-11-16T19:43:28.133Z",
-      "url":"http://feeds.feedwrench.com/websecwarriors.rss"
-   },
-   {
-      "_id":"564a3ddbe51cc00003000217",
-      "author":null,
-      "created_at":"2015-11-16T20:34:35.791Z",
-      "description":"Podcasts produzidos de 2008 a 2010 sobre jogos e todos os tipos de assuntos relacionados ao universo e cultura dos vídeogames.",
-      "image":"http://jogabilida.de/wp-content/uploads/2011/12/nl-podcast.png",
-      "keywords":[
-         "Games \u0026 Hobbies",
-         "Video Games"
-      ],
-      "language":"pt-BR",
-      "permalink":"http://jogabilida.de/",
-      "published":true,
-      "title":"Podcast NowLoading",
-      "updated_at":"2015-11-16T23:00:23.963Z",
-      "url":"http://feeds.feedburner.com/podcastnowloading"
-   },
-   {
-      "_id":"564b9cfe08602e00030000fa",
-      "author":null,
-      "created_at":"2015-11-17T21:32:46.210Z",
-      "description":"Being Boss is a podcast for creative entrepreneurs. From Emily Thompson and Kathleen Shannon. Get your business together. Being boss is hard. Making a dream job of your own isn't easy. But getting paid for it, becoming known for it, and finding purpose in it, is so doable - if you do the work.",
-      "image":"http://www.lovebeingboss.com/img/skin/Header_WhiteLogo.png",
-      "keywords":[
-
-      ],
-      "language":null,
-      "permalink":"http://www.lovebeingboss.com/",
-      "published":true,
-      "title":"Being Boss // A Podcast for Creative Entrepreneurs",
-      "updated_at":"2015-11-17T21:32:50.672Z",
-      "url":"http://www.lovebeingboss.com/RSSRetrieve.aspx?ID=18365\u0026Type=RSS20"
-   },
-   {
-      "_id":"564c5c8008602e0003000128",
-      "author":null,
-      "created_at":"2015-11-18T11:09:52.991Z",
-      "description":"O mundo pop vira piada no Jovem Nerd",
-      "image":"http://jovemnerd.ig.com.br/wp-content/themes/jovemnerd_v2b/images/NC_FEED.jpg",
-      "keywords":[
-         "Society \u0026 Culture"
-      ],
-      "language":"pt-BR",
-      "permalink":"http://jovemnerd.com.br/",
-      "published":true,
-      "title":"Nerdcast",
-      "updated_at":"2015-11-18T11:11:20.034Z",
-      "url":"http://jovemnerd.com.br/categoria/nerdcast/feed/"
-   }
-]

package/tests/strings2.json

@@ -1 +0,0 @@
-["metadata","Designs","Randomized Controlled Trial","Types","BriefSummary","To determine the efficacy, long-term safety, and tolerability of alirocumab , mg every ,\n weeks (Q,W), in comparison with placebo, as well as its potential as a starting regimen. The\n dose regimen of , mg every , weeks (Q,W), as used in other studies, was added as a\n calibrator.","Abstract","To determine the efficacy, long-term safety, and tolerability of alirocumab , mg every ,\n weeks (Q,W), in comparison with placebo, as well as its potential as a starting regimen. The\n dose regimen of , mg every , weeks (Q,W), as used in other studies, was added as a\n calibrator.","Acronym","null","ArticleId","Qy,gwKWSoaWRmbmFEQA","Authors","null","CochraneID","null","Confidential","false","CorporateAuthor","null","Country","Bulgaria, Canada, Hungary, Israel, Norway, Slovakia, United Kingdom, United States","CustomData","null","DatabaseType","ClinicalTrials.gov","DOI","null","EmbaseAccessionNumber","null","Emtree","null","ErrataText","null","FullTextURL","null","Institution","null","ISSN","null","Issue","null","JournalTitle","null","MedlineID","null","MeSH","Hypercholesterolemia|Antibodies, Monoclonal","Pages","null","ParentChildStatus","null","ParentID","null","PublicationDate","March","PublicationYear","PubType","null","ReferenceStudy","null","SecondarySourceID","null","Source","Regeneron Pharmaceuticals","SourceReferenceId","NCT","TaStudyDesign","Randomized","Title","A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of an Every Four Weeks Treatment Regimen of Alirocumab in Patients With Primary Hypercholesterolemia","TrialOutcome","null","Volume","null","Id","Created","VersionNo","ExtractData","null","Digitized","null","IsRapidExtract","false","IsUploaded","false","design","Randomized Controlled Trial","conditions","label","Cholesterol Total Increased","id","SUE_c","phase","name","NCT","trialIds","NCT","acronyms","outcomeCount","id","groups","Id","RefId","B,|O,~Alirocumab , mg Q,W/Up , mg Q,W Without Concomitant Statin","OriginalName","Alirocumab , mg Q,W/Up , mg Q,W Without Concomitant Statin","N","age","ageSD","male","Interventions","termIds","SUBYEL","SUB_Oc","SUNUVb","analyzeAs","Alirocumab","analyzableScore","matchingScore","Id","zB","RefId","B,|O,~Alirocumab , mg Q,W/Up , mg Q,W Without Concomitant Statin","OriginalName","Alirocumab , mg Q,W/Up , mg Q,W Without Concomitant Statin","N","age","ageSD","male","Interventions","termIds","SUBYEL","SUB_Oc","analyzeAs","Statins","analyzableScore","matchingScore","Id","RefId","B,|O,~Placebo Q,W Without Concomitant Statin","OriginalName","Placebo Q,W Without Concomitant Statin","N","age","ageSD","male","Interventions","termIds","SUGeLS","SUBYEL","SUB_Oc","analyzeAs","Control","analyzableScore","matchingScore","Id","tv","RefId","OriginalName","Alirocumab , mg Q,W/Up , mg Q,W","Interventions","termIds","SUCO","SUNUVb","Id","jt","RefId","B,|O,~Alirocumab , mg Q,W/Up , mg Q,W With Concomitant Statin","OriginalName","Alirocumab , mg Q,W/Up , mg Q,W With Concomitant Statin","N","age","ageSD","male","Interventions","termIds","SUBYEL","SUB_Oc","Id","RefId","OriginalName","Alirocumab , mg Q,W/Up , mg Q,W","Interventions","termIds","SUNUVb","Id","RefId","B,|O,~Alirocumab , mg Q,W/Up , mg Q,W With Concomitant Statin","OriginalName","Alirocumab , mg Q,W/Up , mg Q,W With Concomitant Statin","N","age","ageSD","male","Interventions","termIds","SUBYEL","SUB_Oc","SUNUVb","Id","Interventions","Id","Ya","Name","Treatments","Id","((","Phase","k)","Type","Drug","termIds","SUGeLS","SUNUVb","terms","Placebo","Alirocumab","Id","o)","Name","Treatments","Id","Phase","k)","Type","Drug","termIds","SUBYEL","terms","Statins","RefId","E,|Placebo Q,W","OriginalName","Placebo Q,W","Id","Ls","RefId","B,|O,~Placebo Q,W With Concomitant Statin","OriginalName","Placebo Q,W With Concomitant Statin","N","age","ageSD","male","Interventions","termIds","SUGeLS","SUBYEL","SUB_Oc","hasDocData","null","hasRapidExtract","false","N","queryScore","matchingScore","score","outcomes","id","type","Change","unit","%","termIds","SUF,R","SUBskP","quantifiers","name","Calculated LDL-C in Not Receiving Concomitant Statin Therapy - On-Treatment Analysis","cells","number","unit","%","group","!","varType","se","N","se","sd","number","unit","%","group","varType","se","N","se","sd","number","unit","%","group","zB","varType","se","N","se","sd","time","Id","Low","Value","Baseline","High","Number","Unit","wk","Type","Total","days","description","wk","score","matchingTerm","SUF,R","suggestedPositive","false","sourceUnit","%","id","type","Change","unit","%","termIds","SUF,R","SUBskP","quantifiers","name","Calculated LDL-C in Receiving Concomitant Statin Therapy - On-Treatment Analysis","cells","number","unit","%","group","Ls","varType","se","N","se","sd","number","unit","%","group","varType","se","N","se","sd","number","unit","%","group","jt","varType","se","N","se","sd","time","Id","Low","Value","Baseline","High","Number","Unit","wk","Type","Total","days","description","wk","score","matchingTerm","SUF,R","suggestedPositive","false","sourceUnit","%","id","type","Change","unit","%","termIds","SUF,R","SUBskP","quantifiers","name","Calculated LDL-C in Not Receiving Concomitant Statin Therapy - On-Treatment Analysis","cells","number","unit","%","group","varType","se","N","se","sd","number","unit","%","group","varType","se","N","se","sd","number","unit","%","group","zB","varType","se","N","se","sd","time","Id","Low","Value","Baseline","High","Number","Unit","wk","Type","Total","days","description","score","matchingTerm","SUF,R","suggestedPositive","false","sourceUnit","%","id","type","Change","unit","%","termIds","SUF,R","SUBskP","quantifiers","name","Calculated LDL-C in Receiving Concomitant Statin Therapy - On-Treatment Analysis","cells","number","unit","%","group","Ls","varType","se","N","se","sd","number","unit","%","group","E","varType","se","N","se","sd","number","unit","%","group","jt","varType","se","N","se","sd","time","Id","Low","Value","Baseline","High","Number","Unit","wk","Type","Total","days","description","wk","score","matchingTerm","SUF,R","suggestedPositive","false","sourceUnit","%","characteristics","id","type","Binary","isCharacteristic","null","termIds","SUE_c","SUCbN","SUyJj","quantifiers","name","Patients not having adequate control of their hypercholesterolemia based on their individual level of CVD risk","cells","number","outcomesScore"]